Stockholm - Free Realtime Quote SEK
Isofol Medical AB (publ) (ISOFOL.ST)
As of 1:41 PM GMT+1. Market Open.
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Petter Segelman Lindqvist | Chief Executive Officer | -- | -- | -- |
| Ms. Margareta Hagman M.B.A. | Chief Financial Officer | -- | -- | 1966 |
| Dr. Roger Tell M.D., Ph.D. | Chief Medical Officer | -- | -- | 1965 |
Isofol Medical AB (publ)
Biotech Center
Arvid Wallgrens Backe 20
Gothenburg, 413 46
Sweden
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 4
Description
Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden.
Corporate Governance
Isofol Medical AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 12, 2024 at 10:59 AM UTC
Isofol Medical AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
ABLI.ST Abliva AB (publ)
0.1546
+3.34%
ATORX.ST Alligator Bioscience AB (publ)
0.6770
-5.97%
ONCO.ST Oncopeptides AB (publ)
2.0700
-0.48%
ACTI.ST Active Biotech AB (publ)
0.1638
-1.80%
COMBI.ST CombiGene AB (publ)
2.6800
+4.69%
CANTA.ST Cantargia AB (publ)
3.0000
-1.96%
DIABIO.ST Diagonal Bio AB (publ)
0.0320
-3.90%
EGTX.ST Egetis Therapeutics AB (publ)
4.1100
-0.72%
KAN.ST Kancera AB (publ)
1.5220
-6.97%
XBRANE.ST Xbrane Biopharma AB (publ)
0.2050
-7.87%